Articles published in Brain Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Brain Disorders & Therapy has got h-index 12, which means every article in Brain Disorders & Therapy has got 12 average citations.
Following are the list of articles that have cited the articles published in Brain Disorders & Therapy.
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Year wise published articles |
46 | 13 | 13 | 11 | 16 |
Year wise citations received |
103 | 84 | 90 | 74 | 83 |
Journal total citations count | 713 |
Journal h-index | 12 |
This file was downloaded from: http://eprints. qut. edu. au/79677
A shared comparison of diabetes mellitus and neurodegenerative disorders
Colony stimulating factors in the nervous system
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Biochemistry & Molecular Biology Letters
Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
Anterior Spinal Artery Thrombosis Following Trivial Trauma in A Young Girl-Case Report and Review of Literature
Predicting the severity of the course of spinal cord injury
Research & Reviews: Journal of Medical and Health Sciences
Features of intensive care of spinal cord injury
Correlation of the vascular factor with the severity of the condition of patients with spinal cord injury
Pharmacological prospects for the treatment of spinal cord injury in the acute and early periods
ANALYSIS OF INTENSIVE CARE AND THE CAUSES OF MORTALITY IN PATIENTS WITH SPINAL INJURY
Features of blood circulation in the vertebrobasilar basin in patients with cervical spinal cord injury
Innovative approaches in the field of cardiology
Analysis of results of the surgical treatment of the spinal cord injury (step by step)
Construction and identification of GCA fusion gene recombinant BCG shuttle plasmid
Expression of GM-CSF and Epstein-Barr virus LMP2 A fusion gene and its anti-tumor properties
Pro-inflammatory cytokine GM-CSF improves learning/memory and brain pathology in Dp16 down syndrome mice and improves learning/memory in wild-type mice
Drug treatments in development for Alzheimer’s disease